Improving the morbidity of anorectal injury from pelvic radiotherapy

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
F AbbasakoorP B Boulos

Abstract

Radiation anorectal injury due to pelvic radiotherapy for non intestinal cancer is a significant cause of morbidity which may limit the treatment dose required. Conservative treatment options are of limited value and surgery is reserved only for the most severe complications. This review addresses radioprotection of the anorectum and aims to increase awareness amongst surgeons of the strategies that have been in practice in order to minimize the side-effects of radiotherapy while preserving its therapeutic efficacy. This review is based on a literature search (Medline and NLM PubMed) with manual cross-referencing of all articles related to anorectal radiation injury. Optimization of radiation dose, the use of radioprotective agents and improvement in radiation delivery are the main areas of development. There are few data on the potential of altered fractionation schedules in reducing anorectal injury. A few phase I and II studies suggest that the pharmacological agents amifostine and misoprostol could be beneficial in limiting radiation damage but larger phase III studies are awaited. The introduction of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy has been the most significant advance in...Continue Reading

References

Oct 1, 1992·Annals of Surgery·J P DelaneyP Hall
Jun 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R HenrikssonB Littbrand
Aug 1, 1990·International Journal of Radiation Oncology, Biology, Physics·M W DionB Anderson
Jul 1, 1989·International Journal of Radiation Oncology, Biology, Physics·M W DionJ W Osborne
Sep 1, 1986·Gastroenterology·H G FranceC M Mansbach
Jan 1, 1987·Prostaglandins·W R Hanson, K DeLaurentiis
Nov 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F EdsmyrB Nilsson
Feb 1, 1986·International Journal of Radiation Oncology, Biology, Physics·H ItoL Milas
Aug 1, 1972·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·K N Prasad
Sep 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M V WilliamsJ F Fowler
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Oct 1, 1995·Annals of Surgery·I FelemoviciusJ P Delaney
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J D CoxT F Pajak
Sep 30, 1994·International Journal of Radiation Oncology, Biology, Physics·K J StelzerT W Griffin
Jul 1, 1994·Journal of Gastroenterology and Hepatology·M G KormanH Glise
Jan 1, 1995·International Journal of Radiation Oncology, Biology, Physics·G E HanksB Epstein
Jan 1, 1995·International Journal of Radiation Oncology, Biology, Physics·W J KohT W Griffin
Nov 1, 1993·American Journal of Surgery·J P DelaneyI Felemovicius
Feb 1, 1996·Diseases of the Colon and Rectum·T J SaclaridesA Doolas
Feb 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A PollackI I Rosen
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J A MartensonR L Deming
Aug 1, 1996·Endoscopy·C BarbatzasC Carbatzas
Jan 1, 1997·Stem Cells·D M Reese, D J Slamon
Jul 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M ResbeutT D N'Guyen
Jan 10, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P C O'BrienJ W Denham
Mar 7, 1998·International Journal of Radiation Biology·I FelemoviciusJ P Delaney
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·M J ZelefskyZ Fuks
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·G E HanksM A Hunt
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·P C KoperP C Levendag
Apr 7, 1999·International Journal of Radiation Oncology, Biology, Physics·D J Brenner, E J Hall
May 4, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G MitchellC Harmer
Jun 12, 1999·American Journal of Surgery·S F CounterM J Hart
Jul 30, 1999·Gastrointestinal Endoscopy·R A SilvaR L Viana
Jan 19, 2000·Cell Death and Differentiation·R A Knight
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·E E YeohW Sun
Oct 6, 2000·International Journal of Radiation Oncology, Biology, Physics·M R StoreyI Rosen
Aug 8, 2001·The British Journal of Surgery·D HayneP B Boulos
Oct 13, 2001·International Journal of Radiation Oncology, Biology, Physics·A KneeboneG Delaney

❮ Previous
Next ❯

Citations

May 15, 2007·International Journal of Colorectal Disease·Alexander P PietschErnst Klar
Dec 14, 2007·La Presse médicale·Vincent de ParadesPatrick Atienza
Jun 20, 2008·The American Journal of Gastroenterology·Chaysavanh ManichanhJuan-Ramon Malagelada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.